These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, Otsuka Y, Sakamoto S, Ohata K, Goto T, Hara M. J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366 [Abstract] [Full Text] [Related]
3. Clinical usefulness of 11C-MET PET and 201T1 SPECT for differentiation of recurrent glioma from radiation necrosis. Sonoda Y, Kumabe T, Takahashi T, Shirane R, Yoshimoto T. Neurol Med Chir (Tokyo); 1998 Jun; 38(6):342-7; discussion 347-8. PubMed ID: 9689817 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of 11C-methionine PET for differentiation of recurrent brain tumors from radiation necrosis after radiotherapy. Terakawa Y, Tsuyuguchi N, Iwai Y, Yamanaka K, Higashiyama S, Takami T, Ohata K. J Nucl Med; 2008 May; 49(5):694-9. PubMed ID: 18413375 [Abstract] [Full Text] [Related]
8. Semiquantitative analysis using thallium-201 SPECT for differential diagnosis between tumor recurrence and radiation necrosis after gamma knife surgery for malignant brain tumors. Matsunaga S, Shuto T, Takase H, Ohtake M, Tomura N, Tanaka T, Sonoda M. Int J Radiat Oncol Biol Phys; 2013 Jan 01; 85(1):47-52. PubMed ID: 22541963 [Abstract] [Full Text] [Related]
10. The value of 11C-methionine PET in the early differentiation between tumour recurrence and radionecrosis in patients treated for a high-grade glioma and indeterminate MRI. Garcia JR, Cozar M, Baquero M, Fernández Barrionuevo JM, Jaramillo A, Rubio J, Maida G, Soler M, Riera E. Rev Esp Med Nucl Imagen Mol; 2017 Jan 01; 36(2):85-90. PubMed ID: 27503425 [Abstract] [Full Text] [Related]
11. Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma. Jung TY, Min JJ, Bom HS, Jung S, Kim IY, Lim SH, Kim DY, Kwon SY. Neurosurg Rev; 2017 Apr 01; 40(2):223-229. PubMed ID: 27282449 [Abstract] [Full Text] [Related]
12. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis. Travers S, Joshi K, Miller DC, Singh A, Nada A, Biedermann G, Cousins JP, Litofsky NS. World Neurosurg; 2021 Jul 01; 151():e1059-e1068. PubMed ID: 34052453 [Abstract] [Full Text] [Related]
13. Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment. Minamimoto R, Saginoya T, Kondo C, Tomura N, Ito K, Matsuo Y, Matsunaga S, Shuto T, Akabane A, Miyata Y, Sakai S, Kubota K. PLoS One; 2015 Jul 01; 10(7):e0132515. PubMed ID: 26167681 [Abstract] [Full Text] [Related]
20. An interindividual comparison of O-(2-[18F]fluoroethyl)-L-tyrosine (FET)- and L-[methyl-11C]methionine (MET)-PET in patients with brain gliomas and metastases. Grosu AL, Astner ST, Riedel E, Nieder C, Wiedenmann N, Heinemann F, Schwaiger M, Molls M, Wester HJ, Weber WA. Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1049-58. PubMed ID: 21570201 [Abstract] [Full Text] [Related] Page: [Next] [New Search]